Effect of chronic alcohol consumption on Hepatic SIRT1 and PGC-1α in rats

Biochemical and Biophysical Research Communications

Volumn 370, Issue 1, 2008, Pages 44-48

  Lieber, Charles S ^a,b   Leo, Maria A ^a,b   Wang, Xiaolei ^b   DeCarli, Leonore M ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Alcohol; CYP2E1; Medium chain triglycerides; PGC 1 ; SIRT1

Indexed keywords

ALCOHOL; LONG CHAIN TRIACYLGLYCEROL; MEDIUM CHAIN TRIACYLGLYCEROL; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; SIRTUIN 1;

ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET THERAPY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY METABOLISM; INHIBITION KINETICS; LIVER DYSFUNCTION; MALE; METABOLIC REGULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRANSCRIPTION REGULATION;

ALCOHOL DRINKING; ANIMALS; DIET; DOWN-REGULATION; ENERGY METABOLISM; ETHANOL; LIVER; MALE; PPAR GAMMA; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; RNA-BINDING PROTEINS; SIRTUINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRIGLYCERIDES;

RATTUS;

EID: 41849102675     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.03.005     Document Type: Article

References (29)

1. Lieber C.S. Cytochrome P-4502E1: its physiological and pathological role. Lieber CS. 2000. Alcohol: its metabolism and interaction with nutrients. Annu. Rev. Nutr. 20 (1997) 95-430
2. Lieber C.S. Alcoholic liver disease: new insights in pathogenesis lead to new treatments. J. Hepatol. 32 (2000) 113-128
3. Cahill A., Hershman S., Davies A., and Sykora P. Ethanol feeding enhances age-related deterioration of the rat hepatic mitochondrion. Am. J. Physiol. Gastrointest. Liver Physiol. 289 (2005) G1115-G1123
4. Demeilliers C., Maisonneuve C., Grodet A., Mansouri A., Nguyen R., Tinel M., Letteron P., Degott C., Feldmann G., and Pessayre D. B fromenty impaired adaptive resynthesis and prolonged depletion of hepatic mitochondrial DNA after repeated alcohol binges in mice. Gastroenterology 123 (2002) 278-1290
5. Begriche K., Igoudjil A., Pessayre D., and Fromenty B. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 6 (2006) 1-28
6. Nagy L.E. Molecular aspects of alcohol metabolism: transcription factors involved in early ethanol-induced liver injury. Annu. Rev. Nutr. 24 (2004) 55-78
7. Imai S., Armstrong C.M., Kaeberlein M., and Guarente L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403 (2000) 95-800
8. Vaziri H., Dessain S.K., Ng Eaton E., Imai S.I., Frye R.A., Pandita T.K., Guarente L., and Weinberg R.A. hSIR2 (SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107 (2001) 149-159
9. Nemoto S., Fergusson M.M., and Finkel T. SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1α. J. Biol. Chem. 280 (2005) 16456-16460
10. Rhee J., Inoue Y., Yoon J.C., Puigserver P., Fan M., Gonzalez F.J., and Spiegelman B.M. Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1α): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis. Proc. Natl. Acad. Sci. USA 100 (2003) 4012-4017
11. Rodgers J.T., Lerin C., Haas W., Gygi S.P., Spiegelman B.M., and Puigserver P. Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1. Nature 434 (2005) 113-118
12. Schwer B., Bunkenborg J., Verdin R.O., Andersen J.S., and Verdin E.. Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase. Proc. Natl. Acad. Sci. USA 103 (2006) 10224-10229
13. Yamamoto H., Schoonjans K., and Auwerx J. Sirtuin functions in health and disease. Mol. Endocrinol. 21 (2007) 745-1755
14. Yu S., Matusue K., Kashireddy P., Cao W.Q., Yeldandi V.., Yeldandi A.V., et al. Adypocytes-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferators-activated receptor gamma1 (PPARγ-1) expression. J. Biol. Chem. 278 (2003) 498-505
15. Lieber C.S., Cao Q., DeCarli L.M., Leo M.A., Mak K.M., Ponomarenko A., Ren C., and Wang X. Role of medium-chain triglycerides in the alcohol-mediated cytochrome P450 2E1 induction of mitochondria. Alcohol Clin. Exp. Res. 31 (2007) 1660-1668
16. Lieber C.S., and DeCarli L.M. Animal models of chronic ethanol toxicity. In: Packer L. (Ed). Methods in Enzymology: Oxygen Radical in Biological Systems 233 (1994), Academic Press, Inc., Orlando, FL 585
17. Lopez-Lluch G., Hunt N., Jones B., Zhu M., Jamieson H., Hilmer S., Cascajo M.V., Allard J., Ingram D.K., Navas P., and de Cabo R. Calorie restriction induces mitochondrial biogenesis and bioenergetic efficiency. Proc. Natl. Acad. Sci. USA 103 (2006) 1768-1773
18. In: Lieber C.S. (Ed). Medical and Nutritional Complications of Alcoholism: Mechanisms and Management (1992), Plenum Press, New York 579
19. Venkatraman A., Landar A., Davis A.J., Chamlee L., Sanderson T., Kim H., Page G., Pompilius M., Ballinger S., Darley-Usmar V., and Bailey S.M. Modification of the mitochondrial proteome in response to the stress of ethanol-dependent hepatotoxicity. J. Biol. Chem. 279 (2004) 22092-22101
20. Green D.R., and Reed J.C. Mitochondria and apoptosis. Science 281 (1998) 1309-1312
21. Piruat J.I., and Lopez-Barneo J. Oxygen tension regulates mitochondrial DNA-encoded complex I gene expression. J. Biol. Chem. 280 (2005) 42676-42684
22. Freyssenet D. Energy sensing and regulation of gene expression in skeletal muscle. J. Appl. Physiol. 102 (2007) 529-540
23. Lieber C.S. Pathogenesis and treatment of alcoholic liver disease: progress over the last 50 years. Ann. Acad. Med. Bialo. 50 (2005) 7-20
24. Lieber C.S., Lefevre A., Spritz N., Feinman L., and DeCarli L.M. Difference in hepatic metabolism of long and medium-chain fatty acids: the role of fatty acid chain length in the production of the alcoholic fatty liver. J. Clin. Invest. 46 (1967) 1451-1460
25. Geliebter A., Torbay N., Bracco F.E., Hashim S.A., and Van Itallie T.B. Overfeeding with medium-chain triglyceride diet results in diminished deposition of fat. Am. J. Clin. Nutr. 37 (1983) 1-4
26. St-Onge M.P., and Jones P.J. Physiological effects of medium-chain triglycerides: potential agents in the prevention of obesity. J. Nutr. 132 (2002) 329-332
27. Fan Review S.T. Nutritional support for patients with cirrhosis. J. Gastroenterol. Hepatol. 12 (1997) 282-286
28. Kono H., Enomoto N., Connor H.D., Wheeler M.D., Bradford B.U., Rivera C.A., Kadiiska M.B., Mason R.P., and Thurman R.G. Medium-chain triglycerides inhibit free radical formation and TNF-α production in rats given enteral ethanol. Am. J. Physiol. Gastrointest. Liver Physiol. 278 (2000) G467-G476
29. Kono H., Fujii H., Asakawa M., Matsuda M., Maki A., and Matsumoto Y. Protective effects of medium-chain triglycerides on the liver and gut in rats administered endotoxin. Ann. Surg. 237 (2003) 246-255